|
JNJ
|
Johnson & Johnson
|
22.59%
|
US
|
NYSE
|
|
LLY
|
Eli Lilly and Company
|
18.27%
|
US
|
NYSE
|
|
VTRS
|
Viatris Inc.
|
4.93%
|
US
|
NASDAQ
|
|
MRK
|
Merck & Company, Inc.
|
4.63%
|
US
|
NYSE
|
|
PFE
|
Pfizer, Inc.
|
4.50%
|
US
|
NYSE
|
|
ZTS
|
Zoetis Inc.
|
4.36%
|
US
|
NYSE
|
|
JAZZ
|
Jazz Pharmaceuticals plc
|
4.13%
|
US
|
NASDAQ
|
|
BMY
|
Bristol-Myers Squibb Company
|
4.06%
|
US
|
NYSE
|
|
RPRX
|
Royalty Pharma plc
|
4.02%
|
US
|
NASDAQ
|
|
CTLT
|
Catalent, Inc.
|
3.54%
|
US
|
NYSE
|
|
OGN
|
Organon & Co.
|
3.06%
|
US
|
NYSE
|
|
ELAN
|
Elanco Animal Health Incorporated
|
2.34%
|
US
|
NYSE
|
|
PRGO
|
Perrigo Company
|
2.01%
|
US
|
NYSE
|
|
ITCI
|
Intra-Cellular Therapies Inc.
|
1.89%
|
US
|
NASDAQ
|
|
MDGL
|
Madrigal Pharmaceuticals, Inc.
|
1.41%
|
US
|
NASDAQ
|
|
PBH
|
Prestige Brand Holdings, Inc.
|
1.36%
|
US
|
NYSE
|
|
FOLD
|
Amicus Therapeutics, Inc.
|
1.22%
|
US
|
NASDAQ
|
|
AXSM
|
Axsome Therapeutics, Inc.
|
0.96%
|
US
|
NASDAQ
|
|
CORT
|
Corcept Therapeutics Incorporated
|
0.82%
|
US
|
NASDAQ
|
|
CPRX
|
Catalyst Pharmaceutical Partners, Inc.
|
0.78%
|
US
|
NASDAQ
|